Literature DB >> 18465965

Optical coherence tomography measurements of the fresh porcine eye and response of the outer coats of the eye to volume increase.

Magdelena Asejczyk-Widlicka1, Ronald A Schachar, Barbara K Pierscionek.   

Abstract

Corneal and scleral thickness and anterior chamber dimensions are required for understanding developmental and pathological processes. Parameters of the eyeball are also required to calculate optical and material properties. As the eyeball resembles a pressure vessel, it has been suggested that elasticity of the cornea and sclera could be calculated from the measurements of thickness. Baseline corneal and scleral thicknesses and anterior chamber dimensions and how these change with incremental increases of intraocular fluid are measured in fresh porcine eyes using the Visante OCT (optical coherence tomography). At baseline, corneal thickness is almost constant. Anterior scleral thickness is variable, decreasing from 0.91+/-0.07 mm near the limbus to a minimum of 0.58+/-0.13. Posterior scleral thickness is more constant with an average of 0.78+/-0.09 mm. Near the optic nerve the thickness increases to 1.00+/-0.09 mm. Average baseline anterior chamber angle, diameter, and depth were found to be 33.15+/-4.91 deg, 13.60+/-0.38 mm, and 2.13+/-0.22 mm, respectively. After fluid injections, maximum changes in corneal and scleral thicknesses were 9 to 10 and 1 to 3%, respectively. Anterior chamber angle and depth decreased slightly but significantly. Changes in the eyeball coats with fluid injections, indicate that the pressure vessel model can be applied to the eye to calculate corneal and scleral elasticities.

Entities:  

Mesh:

Year:  2008        PMID: 18465965     DOI: 10.1117/1.2907453

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  8 in total

Review 1.  Optical coherence tomography: history, current status, and laboratory work.

Authors:  Michelle L Gabriele; Gadi Wollstein; Hiroshi Ishikawa; Larry Kagemann; Juan Xu; Lindsey S Folio; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-14       Impact factor: 4.799

2.  Comparative optical coherence tomography study of differences in scleral shape between the superonasal and superotemporal quadrants.

Authors:  Masayuki Kasahara; Nobuyuki Shoji; Tetsuya Morita; Kimiya Shimizu
Journal:  Jpn J Ophthalmol       Date:  2014-06-19       Impact factor: 2.447

3.  Finite element modeling of the viscoelastic responses of the eye during microvolumetric changes.

Authors:  Benjamin Cruz Perez; Hugh J Morris; Richard T Hart; Jun Liu
Journal:  J Biomed Sci Eng       Date:  2013-12

4.  Induction of posterior vitreous detachment (PVD) by non-enzymatic reagents targeting vitreous collagen liquefaction as well as vitreoretinal adhesion.

Authors:  Mithun Santra; Maryada Sharma; Deeksha Katoch; Sahil Jain; Uma Nahar Saikia; Mangat R Dogra; Manni Luthra-Guptasarma
Journal:  Sci Rep       Date:  2020-05-19       Impact factor: 4.379

5.  Line-Field Optical Coherence Tomography as a tool for In vitro characterization of corneal biomechanics under physiological pressures.

Authors:  Ahmed Kazaili; Samuel Lawman; Brendan Geraghty; Ashkan Eliasy; Yalin Zheng; Yaochun Shen; Riaz Akhtar
Journal:  Sci Rep       Date:  2019-04-19       Impact factor: 4.379

6.  Simulations of Porcine Eye Exposure to Primary Blast Insult.

Authors:  Richard Watson; Walt Gray; William E Sponsel; Brian J Lund; Randolph D Glickman; Sylvia L Groth; Matthew A Reilly
Journal:  Transl Vis Sci Technol       Date:  2015-08-25       Impact factor: 3.283

7.  Optical Coherence Tomography as a Tool for Ocular Dynamics Estimation.

Authors:  Damian Siedlecki; Waldemar Kowalik; Henryk Kasprzak
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

8.  Development and Characterization of a Benchtop Corneal Puncture Injury Model.

Authors:  Eric J Snider; Lauren E Cornell; Jorge M Acevedo; Brandon Gross; Peter R Edsall; Brian J Lund; David O Zamora
Journal:  Sci Rep       Date:  2020-03-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.